Literature DB >> 8189836

The pharmacology of the integrins.

D Cox1, T Aoki, J Seki, Y Motoyama, K Yoshida.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8189836     DOI： 10.1002/med.2610140203

Source DB:  PubMed          Journal:  Med Res Rev        ISSN： 0198-6325            Impact factor:   12.944


× No keyword cloud information.
  16 in total

Review 1.  Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology.

Authors:  C M Gibson; J L Moynihan; E N Al-Mousa; M Campsey; R Gandhi; S Murphy; S Mattson; K A Ryan; R Mesley; J Swanson; M N Arshad; S J Marble
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

2.  Structural analysis of the KGD sequence loop of barbourin, an alphaIIbbeta3-specific disintegrin.

Authors:  H Minoux; C Chipot; D Brown; B Maigret
Journal:  J Comput Aided Mol Des       Date:  2000-05       Impact factor: 3.686

Review 3.  Cell adhesion molecules: potential therapeutic & diagnostic implications.

Authors:  Shaker A Mousa
Journal:  Mol Biotechnol       Date:  2007-08-15       Impact factor: 2.695

4.  Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel.

Authors:  Anat Eldar-Boock; Keren Miller; Joaquin Sanchis; Ruth Lupu; María J Vicent; Ronit Satchi-Fainaro
Journal:  Biomaterials       Date:  2011-03-04       Impact factor: 12.479

Review 5.  Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours.

Authors:  G Thompson; S J Mills; D J Coope; J P B O'Connor; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 6.  Glycoprotein IIb/IIIa receptor antagonists: clinical pharmacology in cardiovascular diseases of aging.

Authors:  M Sebastian; R Makkar
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

7.  Abciximab in patients with ruptured intracranial aneurysms.

Authors:  Richard I Aviv; Richard O'Neill; Maneesh C Patel; Iain R Colquhoun
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

8.  Structure, sulfatide binding properties, and inhibition of platelet aggregation by a disabled-2 protein-derived peptide.

Authors:  Shuyan Xiao; John J Charonko; Xiangping Fu; Alireza Salmanzadeh; Rafael V Davalos; Pavlos P Vlachos; Carla V Finkielstein; Daniel G S Capelluto
Journal:  J Biol Chem       Date:  2012-09-13       Impact factor: 5.157

9.  Prodrug approach for alphaIIbbeta3-peptidomimetic antagonists to enhance their transport in monolayers of a human intestinal cell line (Caco-2): comparison of in vitro and in vivo data.

Authors:  W Kamm; P Raddatz; J Gante; T Kissel
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

10.  Differences in binding of (99m)Tc-disintegrins to integrin alphavbeta3 on tumor and vascular cells.

Authors:  Linda C Knight; Jan E Romano; Stephen C Cosenza; Nabisa M Iqbal; Cezary Marcinkiewicz
Journal:  Nucl Med Biol       Date:  2007-05       Impact factor: 2.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.